EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lung Cancer Subtyping: A Short Review

Farzana Siddique, Mohamed Shehata iD, Mohammed Ghazal iD, Sohail Contractor, Ayman El-Baz iD

Cancers · 25.07.2024 · 16 (15) · 2643

DOI: 10.3390/cancers16152643 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.07.2024. Verfasst von Farzana Siddique und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Louisville, Louisville, KY 40292, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As of 2022, lung cancer is the most commonly diagnosed cancer worldwide, with the highest mortality rate. There are three main histological types of lung cancer, and it is more important than ever to accurately identify the subtypes since the development of personalized, type-specific targeted therapies that have improved mortality rates. Traditionally, the gold standard for the confirmation of histological subtyping is tissue biopsy and histopathology. This, however, comes with its own challenges, which call for newer sampling techniques and adjunctive tools to assist in and improve upon the existing diagnostic workflow. This review aims to list and describe studies from the last decade (n = 47) that investigate three such potential omics techniques—namely (1) transcriptomics, (2) proteomics, and (3) metabolomics, as well as immunohistochemistry, a tool that has already been adopted as a diagnostic adjunct. The novelty of this review compared to similar comprehensive studies lies with its detailed description of each adjunctive technique exclusively in the context of lung cancer subtyping. Similarities between studies evaluating individual techniques and markers are drawn, and any discrepancies are addressed. The findings of this study indicate that there is promising evidence that supports the successful use of omics methods as adjuncts to the subtyping of lung cancer, thereby directing clinician practice in an economical and less invasive manner.

Schlagwörter

Stichwörter der Autor:innen

immunohistochemistrylung cancer subtypesmetabolomicsproteomicstranscriptomics

Autor:innen und Institutionen

  • Department of Bioengineering, University of Louisville, Louisville, KY 40292, USA.
  • Electrical, Computer, and Biomedical Engineering Department, Abu Dhabi University, Abu Dhabi 59911, United Arab Emirates.
  • Department of Radiology, University of Louisville, Louisville, KY 40202, USA.

ORCID-Profile: Mohamed Shehata, Mohammed Ghazal, Ayman El-Baz

Zitieren

APA

Siddique, F., Shehata, M., Ghazal, M., Contractor, S., & El-Baz, A. (2024). Lung Cancer Subtyping: A Short Review. Cancers, 16(15), 2643. https://doi.org/10.3390/cancers16152643

Vancouver

Siddique F, Shehata M, Ghazal M, Contractor S, El-Baz A. Lung Cancer Subtyping: A Short Review. Cancers. 2024;16(15):2643. doi:10.3390/cancers16152643

BibTeX
@article{Siddique2024,
  author = {Siddique, Farzana and Shehata, Mohamed and Ghazal, Mohammed and Contractor, Sohail and El-Baz, Ayman},
  title = {Lung Cancer Subtyping: A Short Review},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {15},
  pages = {2643},
  doi = {10.3390/cancers16152643}
}
Kostenlos starten →